$50M sweet spot round size
Most of their 15 investments are in rounds between $33M and $80M
2014
Mojia Biotech raised $80M on June 22, 2022
Investors: Temasek, Bits x Bites and LYZZ CAPITAL
Undisclosed raised undisclosed on April 29, 2022
Investors: Jifeng Ventures 济峰资本, IDG Capital Partners and LYZZ CAPITAL
OncoMyx Therapeutics raised $50M on December 9, 2021
Investors: Delos Capital, Korea Investment Partners, City Hill Ventures, Madison Partners, Xeraya Capital, Lumira Ventures, B Capital Group and LYZZ CAPITAL
Undisclosed raised $50M on December 8, 2021
Investors: Delos Capital, Korea Investment Partners, Xeraya Capital, B Capital Group, Lumira Ventures, Madison Partners, City Hill Ventures and LYZZ CAPITAL
Wugen raised $172M on July 15, 2021
Investors: RiverVest Venture Partners, Aisling Capital, Sands Capital Management, Intermediate Capital Group (ICG) and LYZZ CAPITAL
Neurelis, Inc. raised $114M on March 10, 2021
Investors: Decheng Capital and LYZZ CAPITAL
Jumpcode Genomics raised $21M on January 20, 2021
Investors: LYZZ CAPITAL
Onchilles Pharma raised $7M on July 10, 2020
Investors: LYZZ CAPITAL
Undisclosed raised $160M on April 16, 2020
Investors: Yuexiu Financial Industrial Fund, BOCOM International, Lake Bleu Capital (Hong Kong) Limited, 中金公司, 北京亦庄国际投资发展有限公司, 国海证券股份有限公司, CITIC Securities Company Limited and LYZZ CAPITAL
Undisclosed raised undisclosed on December 29, 2018
Investors: 浙江九仁资本管理有限公司 and LYZZ CAPITAL